New multiple sclerosis drug shows promise in advanced stages of the disease
A new multiple sclerosis (MS) drug has shown promise in treating the advanced stages of the neurological disease. The researchers found that the drug can help slow down progression of MS, even in its advanced stages – there is currently no treatment for advanced stages of multiple sclerosis. Known as ocrelizumab, the drug is considered ...click here to read more
